News | May 06, 2023
Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
The collaboration between CORONA and Ferring will cater to patients across India
Pheezee is designed to assess musculoskeletal and neuromuscular health.
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
New agreement applies to the polymers of the Medical Care series portfolio
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Subscribe To Our Newsletter & Stay Updated
